Vicora, Inc.
PrivateLast Round
Seed Round
Apr 1, 2026
Total Funding Raised
$3.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Vicora, Inc. operates in Healthcare & Life Sciences and is based in Buffalo, New York. Its latest recorded funding round was an Early Funding round in May 2025.
Vicora, Inc. is a medical device company that develops innovative catheter systems for the treatment of vascular diseases, including deep vein thrombosis and pulmonary embolism.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vicora, Inc. Comparables
Compare Vicora, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Thrombolex, Inc. | 90% | |
| Innova Vascular | 86% | |
| Akura Medical | 83% |
For institutional investors. Book with your work email.
Vicora, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 1, 2026 | ||||
| Early Funding | May 9, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Vicora, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Egret Healthcare Ventures | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
$2.3M round completed.
- Nov 14, 2025
Grew 60% QoQ from 5 to 8 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingOct 27, 2026
Vicora recently closes a $2.25M funding round, bringing total funding to nearly $6 million plus about $1 million in grants to support product development, testing, and its first-in-human clinical study.
For institutional investors. Book with your work email.
Vicora, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vicora, Inc.'s valuation, stock price, and market status.
Is Vicora, Inc. a public or private company?
Vicora, Inc. is a private company.
What is the current stock price of Vicora, Inc.?
Vicora, Inc. is a private company, so its shares have no public market price. Caplight tracks Vicora, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vicora, Inc. worth (valuation)?
Valuation information for Vicora, Inc. is not publicly available.
Can I buy Vicora, Inc. stock?
Vicora, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vicora, Inc.'s last funding round?
Vicora, Inc.'s most recent funding round was Seed Round on April 1, 2026.
Who are the main investors in Vicora, Inc.?
Key investors in Vicora, Inc. include Egret Healthcare Ventures.
Will Vicora, Inc. IPO soon?
No public IPO plans have been announced for Vicora, Inc..
How can I track Vicora, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Vicora, Inc.'s shares on secondary markets.